Primary sclerosing cholangitis (PSC) is a progressive inflammatory bile duct disease, often associated with inflammatory bowel disease (IBD). Liver transplantation (LT) remains the only curative option and is generally considered in cases of end-stage liver disease, debilitating biliary symptoms, or when bile duct neoplasia is suspected.1
Journal of Hepatology published a clinical update in Research Highlights on 19 Feb 2026.
The item focuses on Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation.
Review the original article for the full source wording and details.